Health Trials

CeraVe Effect on Restoring Skin Hydration as Maintenance Regimen in Subjects With Mild to Moderate Atopic Dermatitis

ConditionAtopic Dermatitis (AD)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-99
SponsorSocieta Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse

About this trial

This is an open-label, randomised, comparative, prospective, interventional study of a cosmetic product.

Eligibility criteria

Qualifiers

None

Disqualifiers

Age <18 years. Participants who are unwilling or unable to give informed consent to participate in the study.

Receiving any systemic treatment for atopic dermatitis (AD), including corticosteroids, cyclosporine, any approved biologics or JAK inhibitors.

Any dermatological disorder which, in the investigator's opinion, may interfere with the accurate evaluation of the subject's skin characteristics (except AD).

Trial design

Treatments tested in this trial

  • CeraVe Moisturizing Cream
  • Galenico

Treatment groups

98 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse

Lead sponsor

Source ClinicalTrials.gov